Cannabis May Ease Restless Legs Syndrome Symptoms, New Scientific Review Finds

A new scientific review suggests that cannabis and cannabinoid-based preparations may help reduce symptoms of restless legs syndrome—even among some patients whose symptoms have not responded adequately to conventional treatments.

The findings do not establish cannabis as a cure or a replacement for established medical care. However, they add to a growing body of evidence indicating that cannabinoids deserve more rigorous clinical study as a potential complementary option for people living with this disruptive neurological condition.

Published in the Annals of the Indian Academy of Neurology, the review evaluated seven studies involving a combined 426 adults with restless legs syndrome, commonly abbreviated as RLS. Participants across the studies used several forms of cannabis and cannabinoid preparations, including botanical cannabis, tinctures and cannabis-infused topical products.

Researchers described the evidence with “cautious optimism.” Their conclusion was measured but important: cannabis and cannabinoids may provide relief for certain patients, including people with refractory RLS, but larger and better-designed clinical trials are still necessary.

This article is based on reporting from our friends at national NORML, the organization whose work inspired our name, our mission and more than five decades of cannabis reform advocacy. Suncoast NORML is proud to carry that legacy forward here in Florida while directing readers to the original national NORML report for its coverage of this developing research.

What Is Restless Legs Syndrome?

Restless legs syndrome is a neurological disorder that causes an overwhelming urge to move the legs. People frequently describe uncomfortable sensations such as pulling, crawling, tingling, throbbing or aching.

RLS symptoms commonly:

• Begin or become worse during periods of rest

• Intensify during the evening or at night

• Improve temporarily with movement

• Interfere with falling asleep or remaining asleep

For some people, RLS is an occasional irritation. For others, it can become a chronic condition that disrupts sleep, concentration, work and overall quality of life.

The National Institute of Neurological Disorders and Stroke explains that treatment may involve addressing an iron deficiency, reviewing medications or underlying conditions, making lifestyle changes and using prescription therapies when appropriate.

What Did the New Cannabis and RLS Review Find?

Researchers affiliated with the All India Institute of Medical Sciences examined evidence from seven studies covering 426 adults with RLS.

The preparations evaluated across the studies were not identical. They included botanical cannabis as well as tinctures and topical cannabinoid products. That variation matters because cannabis is not one standardized medicine. Cannabinoid ratios, doses, delivery methods and product quality can differ significantly.

Even with those limitations, the review found preliminary evidence that cannabis may alleviate or prevent RLS symptoms in some adults. The potential appeared especially noteworthy in refractory cases—situations in which symptoms persist despite standard treatment or a patient cannot tolerate conventional medications.

The review’s authors did not recommend replacing established RLS therapies with cannabis. Instead, they described cannabinoids as a potential adjunct, meaning an option that might eventually be considered alongside accepted treatments for carefully selected patients.

That distinction is essential. The findings are promising, but “promising” is not the same as “proven.”

Why Refractory Restless Legs Syndrome Matters

Refractory restless legs syndrome can be particularly difficult to manage. Some patients experience limited relief from available medications, while others encounter significant side effects.

Certain patients may also experience a worsening pattern known as augmentation. This can cause RLS symptoms to begin earlier in the day, become more intense or spread to other parts of the body.

For people facing these challenges, even an early signal of another possible therapeutic pathway deserves scientific attention.

Cannabis policy has historically made this type of research unnecessarily difficult. When patients report benefits but researchers lack access to large, controlled trials, doctors and patients are left with uncertainty.

Sensible cannabis reform should make it easier—not harder—to study cannabis formulations under carefully controlled conditions.

That is one reason NORML’s work remains so important. Cannabis reform is not only about ending arrests. It is also about removing barriers to scientific research, developing evidence-based regulations and allowing honest conversations between patients and healthcare professionals.

A Separate 2026 Study Reported Sustained Improvements

The new review did not include a more recent observational study from Spain involving 18 patients with RLS.

In that study, participants used an oral spray containing standardized doses of THC and CBD in the evening. Researchers reported improvements in RLS severity and sleep-related measurements after one and three months, with clinical improvement persisting at the one-year follow-up.

Those results are encouraging, but the study was small and open-label, meaning participants and researchers knew which treatment was being used. Without a large, randomized and placebo-controlled trial, it is impossible to determine how much of the reported improvement resulted from the cannabinoid treatment itself.

The study nevertheless provides an additional research signal supporting more definitive clinical trials.

Does CBD Alone Help Restless Legs Syndrome?

The available evidence does not establish CBD alone as a treatment for RLS.

National NORML’s earlier reporting noted that one clinical trial found oral CBD alone ineffective for RLS symptoms among patients with Parkinson’s disease. Other reports have involved botanical cannabis or preparations containing both THC and CBD.

Consumers should therefore be skeptical of blanket claims that any CBD product can treat restless legs syndrome.

Different cannabinoids, ratios, doses and delivery methods may produce very different outcomes. Products sold outside controlled research settings are also not automatically equivalent to the formulations used in clinical studies.

What the Research Does—and Does Not—Tell Us

The review provides a reason to investigate cannabis for RLS more seriously. It does not prove that cannabis works for every patient, establish an ideal dose or identify which formulation may be most effective.

Important unanswered questions include:

• Which cannabinoids are responsible for any observed benefits?

• Is a combination of THC and CBD more effective than either compound alone?

• Which delivery method offers the best balance of benefit and risk?

• How long do the reported improvements last?

• Which patients are most likely to respond?

• What short- and long-term side effects may occur?

• How does cannabinoid therapy compare with established RLS treatments?

Until researchers answer these questions through larger randomized controlled trials, cannabis should be discussed as an emerging area of study rather than a settled treatment.

Patients Should Speak With a Healthcare Professional

Anyone experiencing persistent leg discomfort or serious sleep disruption should seek a proper medical evaluation. RLS symptoms can sometimes be associated with iron deficiency, kidney disease, pregnancy, nerve conditions or medication side effects.

Cannabis can also cause impairment, dizziness, anxiety, changes in attention and interactions with other medications. Product quality and potency vary, and state cannabis laws do not turn preliminary scientific evidence into individualized medical guidance.

Patients should not discontinue prescribed treatment or attempt to self-treat a neurological condition based solely on a news report. A qualified healthcare professional can evaluate possible causes, current medications and evidence-based treatment options.

Why Cannabis Research and Reform Must Move Forward Together

For decades, cannabis policy treated prohibition as a substitute for scientific inquiry. Patients were criminalized, researchers encountered unnecessary barriers and the public received more stigma than reliable information.

That approach has failed.

This review does not justify exaggerated medical claims. It supports something more responsible: allowing scientists to ask better questions, conduct stronger trials and determine where cannabis may—or may not—fit into modern healthcare.

At Suncoast NORML, we believe patients deserve evidence, honest education and laws grounded in science rather than fear. We also recognize that our work in Florida stands on the shoulders of national NORML, which has been fighting to reform marijuana laws since 1970.

Please read and share the original national NORML article about cannabis and restless legs syndrome. Supporting national NORML strengthens the movement that made local chapters—and organizations like Suncoast NORML—possible.

For more evidence-based cannabis research, policy and reform coverage from Florida and across the country, continue following Suncoast NORML.

Frequently Asked Questions

Can cannabis cure restless legs syndrome?

No. Current evidence does not establish cannabis as a cure for restless legs syndrome. Preliminary research suggests that cannabis or cannabinoid preparations may reduce symptoms for some patients, but stronger clinical trials are needed.

What does refractory restless legs syndrome mean?

Refractory RLS refers to symptoms that remain inadequately controlled despite appropriate conventional treatment or cases in which available treatments cause unacceptable side effects.

How many patients were included in the review?

The scoping review examined seven studies involving a combined 426 adults with restless legs syndrome.

Should cannabis replace standard RLS medication?

No. The review positions cannabis and cannabinoids as possible adjuncts—not replacements for established treatments. Patients should consult a qualified healthcare professional before changing any treatment plan.

Is CBD by itself proven to help RLS?

No. CBD alone is not an established RLS treatment. At least one clinical trial referenced by NORML found oral CBD ineffective for RLS symptoms among patients with Parkinson’s disease.